Overview
AlgiSys BioSciences, Inc. has raised $45M in a Series B round on Nov 1, 2021, with participation from Peakstone Securities. The company the Future of Sustainable Solutions for Select Omega Ingredients. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the biotechnology research sector, AlgiSys BioSciences, Inc. is positioned to capitalize on growing demand for innovative solutions in this space. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
With $45M now on the balance sheet, AlgiSys BioSciences, Inc. enters a new phase of growth that typically involves rapid hiring, technology upgrades, and vendor evaluations. For sales professionals and service providers, this represents a prime opportunity to engage while budget allocation decisions are being made and the team is actively building out its operational infrastructure.
Why contact AlgiSys BioSciences, Inc. now
With $45M in fresh capital from Series B, AlgiSys BioSciences, Inc. is entering a rapid growth phase. Post-funding startups typically increase headcount by 30-50% and begin evaluating new tools and services immediately. The founders and decision-makers are actively taking meetings right now — making this the perfect time to connect before their calendars fill up.
Founders & Contacts
Investors
Company Facts
| Company | AlgiSys BioSciences, Inc. |
| Amount Raised | $45M |
| Funding Round | Series B |
| Date Raised | Nov 1, 2021 |
| Founded | 2009 |
| Industry | Biotechnology Research |
| Founders |
Get Verified Founder Emails
Access verified email addresses and contact details for AlgiSys BioSciences, Inc.'s founders and thousands of other funded startups.
Start Free Trial